StockGuru Blog: RxElite Holdings (RXEI) – Sales Continue to Double
Stock Guru Profile News Blogs This company has a good story and a strong story. What we know: Sevoflurane is the most widely used, inhalable anesthetic gas in the world. RxElite is on track in sales. Sales continue to DOUBLE MONTH to MONTH. The price of Sevoflurane has not suffered significant erosion as it becomes generic. SOUT is on target with their distribution of Sevoflurane in capturing the projected 11 to 15 percent of the market in the U.S. Oppenheimer’s October report focuses on the manufacturer of Sevoflurane by Minrad. RXEI is the exclusive U.S. distributor of Sevoflurane for Minrad.…